Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

The US Food and Drug Administration (FDA) has approved INBRIJA – an inhalable drug created by US biotech company Acorda Therapeutics – for intermittent treatment.

INBRIJA is designed to treat Parkinson’s symptoms that occur between oral doses of medication, which are known as ‘off’ episodes. The drug has been approved by the FDA and – after a clinical study involving 900 people with Parkinson’s – is expected to be available in 2019.

Todd Sherer, CEO of The Michael J Fox Foundation, who funded early trials of the powder, said: “Despite being on treatment, patients may experience OFF periods as Parkinson’s progresses, which can be disruptive.

“We knew we had to help address this unmet need, and this approval is a significant step forward for the community as it provides a new option to manage these gaps in symptom control.”

To read more on this topic click here.

For more information on Parkinson’s medication please visit the EPDA website.

Memory loss could be an indication of Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Watch this amazing video of first Parkinson’s treatments from 1963

Uncovered: 50-year-old footage of earliest Parkinson’s treatment

Rich chocolate fondue with strawberries and pineapple

A quick, easy to digest dessert recipe

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

President of APPDE calls PD REHAB trial “damaging”

Can overuse of antibiotics cause Parkinson’s?

Researchers at Helsinki University Hospital, Finland, have found that the overuse of antibiotic drugs could increase the risk of developing Parkinson’s. The study – published in medical journal ‘Movement Disorders’ – compared data on antibiotic exposure in 13,976 people with Parkinson’s and 40,697 people without. The researchers found that overuse of some antibiotic drugs can cause Parkinson’s, that it can take up to 15 years before any symptoms emerge – and that the connection to Parkinson’s could be due to the drug’s effects on the gut. Filip Scheperjans, neurologist and lead researcher of the study, said: “The link between antibiotic exposure and Parkinson’s disease fits the current view that in a significant proportion of patients the pathology of Parkinson’s may originate in the gut, possibly related to microbial changes, years before the onset of typical Parkinson’s symptoms such as slowness, muscle stiffness and shaking of the extremities.”

New Parkinson’s health app to track symptoms more accurately

Health app SleepFit could be used to track Parkinson’s symptoms in real time, providing clinicians with a more accurate view of patients’ condition, according to a new study. As part of the research – published in ‘Journal of Parkinson’s Disease’ – 42 people with Parkinson’s recorded their symptoms on the app four times a day for a period of two weeks. After the study, to test the data against patients’ own recollection of their symptoms, those participating completed a questionnaire – recording symptoms such as walking difficulty and hand dexterity. The results showed that 16.7% of those who took part tended to over or underestimate their symptoms when completing the questionnaire, therefore providing inaccurate information. Dr Pietro Luca Ratti, lead researcher of the study, said: “The importance of accurately assessing motor symptoms is pivotal in the clinical follow-up of patients with Parkinson’s Disease.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Watch this amazing video of first Parkinson’s treatments from 1963

Recipes & Nutrition

Rich chocolate fondue with strawberries and pineapple

Special reports

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

Queen Elizabeth II honours UK university for Parkinson’s research

Can overuse of antibiotics cause Parkinson’s?

New Parkinson’s health app to track symptoms more accurately

{title}

Subscribe

Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Watch this amazing video of first Parkinson’s treatments from 1963

Recipes & Nutrition

Rich chocolate fondue with strawberries and pineapple

Special reports

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

Queen Elizabeth II honours UK university for Parkinson’s research

Can overuse of antibiotics cause Parkinson’s?

New Parkinson’s health app to track symptoms more accurately

{title}

Subscribe

Sign in